...
首页> 外文期刊>Acta Cardiologica >HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia.
【24h】

HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia.

机译:冠状动脉扩张症患者的HLA-DR B1和DQ B1多态性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: The purpose of our study was to evaluate the significance of polymorphisms in HLA class II genes in coronary artery ectasia (CAE) patients. METHODS AND RESULTS: Twenty-six patients with CAE without associated cardiac defects were enrolled in the study. CAE was defined as luminal dilation of 1.5- to 2.0-fold of normal limits. Ninety-five healthy subjects who were donors for different organ transplantations, were chosen as control group. Physical examination, electrocardiography and chest X-ray were completely normal in these cases. Both the patients and the control group were screened and compared for their HLA class II genotypes. HLA-DR B1*13, DR16, DQ2 and DQ5 genotypes were significantly more frequent in the patient group.When the known risk factors of coronary heart disease were compared in the patients carrying these genotypes with the non-carrying group, no significant differences were encountered. CONCLUSIONS: HLA-DR B1*13, DR16, DQ2 and DQ5 may be associated with the pathogenesis andincrease the risk of CAE.
机译:目的:本研究的目的是评估冠状动脉扩张(CAE)患者HLA II类基因多态性的重要性。方法和结果:26例无相关心脏缺陷的CAE患者入选了该研究。 CAE被定义为正常极限值的1.5到2.0倍的管腔扩张。作为不同器官移植的供体的九十五名健康受试者被选为对照组。在这些情况下,体格检查,心电图和胸部X线检查完全正常。筛选患者和对照组,并比较其HLA II类基因型。 HLA-DR B1 * 13,DR16,DQ2和DQ5基因型在患者组中更为频繁。当比较携带这些基因型的患者与非携带者的冠心病的已知危险因素时,无显着差异遇到。结论:HLA-DR B1 * 13,DR16,DQ2和DQ5可能与CAE的发病机制和风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号